Analysts Anticipate CRH Medical Corporation (CRHM) Will Post Earnings of $0.01 Per Share

Equities analysts expect that CRH Medical Corporation (NASDAQ:CRHM) will post $0.01 earnings per share for the current quarter, Zacks reports. Two analysts have made estimates for CRH Medical’s earnings, with the highest EPS estimate coming in at $0.02 and the lowest estimate coming in at ($0.01). CRH Medical reported earnings per share of $0.02 in the same quarter last year, which suggests a negative year-over-year growth rate of 50%. The business is expected to issue its next quarterly earnings report on Wednesday, August 7th.

According to Zacks, analysts expect that CRH Medical will report full year earnings of $0.13 per share for the current fiscal year, with EPS estimates ranging from $0.02 to $0.37. For the next year, analysts anticipate that the company will report earnings of $0.17 per share, with EPS estimates ranging from $0.03 to $0.37. Zacks’ earnings per share calculations are a mean average based on a survey of sell-side research firms that that provide coverage for CRH Medical.

CRH Medical (NASDAQ:CRHM) last released its earnings results on Wednesday, March 13th. The company reported $0.02 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.02. The firm had revenue of $32.02 million during the quarter, compared to analyst estimates of $31.40 million.

Separately, Clarus Securities reissued a “buy” rating on shares of CRH Medical in a research note on Wednesday, March 20th.

Shares of NASDAQ CRHM traded down $0.02 during midday trading on Tuesday, hitting $2.88. The stock had a trading volume of 84,800 shares, compared to its average volume of 76,971. CRH Medical has a fifty-two week low of $2.51 and a fifty-two week high of $4.50.

About CRH Medical

CRH Medical Corporation provides various products and services to gastroenterologists for the treatment of gastrointestinal diseases in the United States, Canada, and internationally. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid.

Featured Article: Discover Your Risk Tolerance

Get a free copy of the Zacks research report on CRH Medical (CRHM)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with's FREE daily email newsletter.